<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Tian C</submitter><pubmed_abstract>The emergence of carbapenemase-producing &lt;i>Acinetobacter&lt;/i> spp. has been widely reported and become a global threat. However, carbapenem-resistant &lt;i>A. johnsonii&lt;/i> strains are relatively rare and without comprehensive genetic structure analysis, especially for isolates collected from human specimen. Here, one &lt;i>A. johnsonii&lt;/i> AYTCM strain, co-producing NDM-1, OXA-58, and PER-1 enzymes, was isolated from sputum in China in 2018. Antimicrobial susceptibility testing showed that it was resistant to meropenem, imipenem, ceftazidime, ciprofloxacin, and cefoperazone/sulbactam. Whole-genome sequencing and bioinformatic analysis revealed that it possessed 11 plasmids. &lt;i>bla&lt;/i> &lt;sub>OXA-58&lt;/sub> and &lt;i>bla&lt;/i> &lt;sub>PER-1&lt;/sub> genes were located in the pAYTCM-1 plasmid. Especially, a com</pubmed_abstract><journal>Frontiers in cellular and infection microbiology</journal><pagination>1227063</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10486904</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Complete genetic characterization of carbapenem-resistant &lt;i>Acinetobacter johnsonii&lt;/i>, co-producing NDM-1, OXA-58, and PER-1 in a patient source.</pubmed_title><pmcid>PMC10486904</pmcid><pubmed_authors>Huang D</pubmed_authors><pubmed_authors>Fan X</pubmed_authors><pubmed_authors>Ren L</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Tian C</pubmed_authors><pubmed_authors>Ying J</pubmed_authors><pubmed_authors>Fu L</pubmed_authors><pubmed_authors>Bai Y</pubmed_authors><pubmed_authors>Ma T</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Complete genetic characterization of carbapenem-resistant &lt;i>Acinetobacter johnsonii&lt;/i>, co-producing NDM-1, OXA-58, and PER-1 in a patient source.</name><description>The emergence of carbapenemase-producing &lt;i>Acinetobacter&lt;/i> spp. has been widely reported and become a global threat. However, carbapenem-resistant &lt;i>A. johnsonii&lt;/i> strains are relatively rare and without comprehensive genetic structure analysis, especially for isolates collected from human specimen. Here, one &lt;i>A. johnsonii&lt;/i> AYTCM strain, co-producing NDM-1, OXA-58, and PER-1 enzymes, was isolated from sputum in China in 2018. Antimicrobial susceptibility testing showed that it was resistant to meropenem, imipenem, ceftazidime, ciprofloxacin, and cefoperazone/sulbactam. Whole-genome sequencing and bioinformatic analysis revealed that it possessed 11 plasmids. &lt;i>bla&lt;/i> &lt;sub>OXA-58&lt;/sub> and &lt;i>bla&lt;/i> &lt;sub>PER-1&lt;/sub> genes were located in the pAYTCM-1 plasmid. Especially, a com</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-04-29T02:18:38.811Z</modification><creation>2025-02-19T04:01:34.231Z</creation></dates><accession>S-EPMC10486904</accession><cross_references><pubmed>37692162</pubmed><doi>10.3389/fcimb.2023.1227063</doi></cross_references></HashMap>